MedPath

A clinical study to evaluate the anti-fatigue effect of S-allylcysteine

Not Applicable
Conditions
one
Registration Number
JPRN-UMIN000030501
Lead Sponsor
Soiken Inc.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
24
Inclusion Criteria

Not provided

Exclusion Criteria

1) Subject receiving a medical treatment for serious renal, hepatic, cardio-vascular, respiratory, endocrine or metabolic disorders or having a medical history of these disorders 2) Subject having the chronic fatigue syndrome (CFS), or subject deemed to have severe fatigue like idiopathic chronic fatigue by the investigator 3) Subject having a medical history of chest pain or syncope 4) Subject having an abnormality in the electrocardiogram 5) Subject having a subjective symptom of low back pain, joint pain or lumber hernia, disease of lower limbs, palpitations 6) Subject who has the possibility of developing allergic symptoms by the test food(gelatin allergy) 7)Subject who has a history of its physical condition getting worse after garlic intake 8)Subject who takes regularly health food containing an ingredient derived from garlic 9) Subject who takes regularly pharmaceuticals or quasi-drugs which having the efficacy for recovery from fatigue or nutrient replenishment in case of physical fatigue 10) Subject who takes regularly Foods with Function Claims labeled the effect of attenuating fatigue sensation 11) Subject who have a seasonal allergic rhinitis (cedar or Japanese cypress pollen) with moderate or severe symptoms 12) Subject having blood sample of 200 ml or more taken within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood) 13) Subject who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study 14) Female subjects who is pregnant or lactating, or intending to become pregnant during the study 15) Subject deemed unsuitable by the investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath